Abstract
Single chain Fv (scFv) antibodies (generated by phage display technology, molecules representing new and efficient tools in the research and diagnostics of infectious diseases) against the capsid protein (p25) of Maedi-Visna virus were selected. Several clones of p25 specific scFv antibodies were identified; one of them was expressed as a soluble scFv molecule, purified by immobilized metal-affinity chromatography and further characterized by sequencing and determination of the kinetic equilibrium association constant. Sequence analysis showed that the rearranged VL and VH domains of the analyzed scFv clone used sequences from the VL3 family (germline DPL16/VL3.1) and VH1 family (germline VH20), respectively. The kinetic equilibrium association constant was determined asK A=1.12 ± 0.52 L/µmol.
Similar content being viewed by others
References
Adams G.P., Schier R.: Generating improved single-chain Fv molecules for tumor targeting.J.Immunol.Meth. 231, 249–260 (1999).
Cardoso D.F., Nato F., England P., Ferreira M.L., Vaughan T.J., Mota I., Mazie J.C., Choumet V., Lafaye P.: Neutralizing human anti-crotoxin seFv isolated from a nonimmunized phage library.Scand.J.Immunol. 51, 337–344 (2000).
Celer V. Jr.,Celer V.: Detection of antibodies to ovine lentivirus using recombinant capsid and transmembrane proteins.J.Vet.Med. 48, 89–95 (2001).
Cochet O., Gruel N., Fridman W.H., Teillaud J.L.: Ras and p53 intracellular targeting with recombinant single-chain Fv (scFv) fragments: a novel approach for cancer therapy?Cancer Detect.Prev. 23, 506–510 (1999).
Fevereiro M., Barros S., Fagulha T.: Development of a monoclonal antibody blocking-ELISA for detection of antibodies against Maedi-Visna virus.J.Virol.Meth. 81, 101–108 (1999).
Gelmetti D., Gibelli L., Brocchi E., Cammarata G.: Using a panel of monoclonal antibodies to detect Maedi virus (MV) in chronic pulmonary distress of sheep.J.Virol.Meth. 88, 9–14 (2000).
Gendelman H.E., Narayan O., Kennedy-Stoskopf S.: Tropism of sheep lentiviruses for monocytes: susceptibility to infection and virus gene expression increase during maturation of monocytes to macrophages.J.Virol. 58, 67–74 (1986).
Griffiths A.D., Williams S.C., Hartley O., Tomlinson I.M., Waterhouse P., Crosby W.L., Kontermann R.E., Jones P.T., Low N.M., Allison T.J.: Isolation of high affinity human antibodies directly from large synthetic repertoires.EMBO J. 13, 3245–3260 (1994).
Gudnadottir M.: Visna-Maedi in sheep.Progr.Med.Virol. 18336–18349 (1974).
de Haard H. J., Kazemier B., Koolen M.J., Nijholt L.J., Meloen R.H., van Gemen B., Hoogenboom H.R., Arends J.W.: Selection of recombinant, library-derived antibody fragments against p24 for human immunodeficiency virus type 1 diagnostics.Clin.Diagn.Lab.Immunol. 5, 636–644 (1998).
Li Y., Cockburn W., Kilpatrick J.B., Whitelam G.C.: High affinity ScFvs from a single rabbit immunized with multiple haptens.Biochem.Biophys.Res.Commun. 268, 398–404 (2000).
Lou J., Marzari R., Verzillo V., Ferrero F., Pak D., Sheng M., Yang C., Sblattero D., Bradbury A.: Antibodies in haystacks: how selection strategy influences the outcome of selection from molecular diversity libraries.J.Immunol.Meth. 253, 233–242 (2001).
Malmborg A.C., Borrebaeck C.A.K.: BIAcore as a tool in antibody engineering.J.Immunol.Meth. 183, 7–13 (1995).
Marasco W.A., La Vecchio J., Winkler A.: Human anti-HIV-1 tat sFv intrabodies for gene therapy of advanced HIV-1-infection and AIDS.J.Immunol.Meth. 231, 223–238 (1999).
Marks J.D., Hoogenboom H.R., Bonnert T.P., McCafferty J., Griffiths A.D., Winter G.: By-passing immunization. Human antibodies from V-gene libraries displayed on phage.J.Mol.Biol. 222, 581–597 (1991).
Mhashilkar A.M., Biswas D.K., La Vecchio J., Pardee A.B., Marasco W.A.: Inhibition of human immunodeficiency virus type 1 replicationin vitro by a novel combination of anti-Tat single-chain intrabodies and NF-κB antagonists.J.Virol. 71, 6486–6494 (1997).
Muller B.H., Lafay F., Demangel C., Perrin P., Tordo N., Flamand A., Lafaye P., Guesdon J.L.: Phage-displayed and soluble mouse scFv fragments neutralize rabies virus.J.Virol.Meth. 67, 221–233 (1997).
Power B.E., Hudson P.J.: Synthesis of high avidity antibody fragments (scFv multimers) for cancer imaging.J.Immunol.Meth. 242, 193–204 (2000).
Schuck P.: Kinetics of ligand binding to receptor immobilized in a polymer matrix, as detected with an evanescent wave biosensor A computer simulation of the influence of mass transport.Biophys.J. 70, 1230–1249 (1996).
Sheets M.D., Amersdorfer P., Finnern R., Sargent P., Lindquist E., Schier R., Hemingsen G., Wong C., Gerhart J.C., Marks J.D., Lindqvist E.: Efficient construction of a large non-immune phage antibody library: the production of high-affinity human single-chain antibodies to protein antigens.Proc.Nat.Acad.Sci.USA 95, 6157–6162 (1998).
Sonigo P., Alizon M., Staskus K., Klatzmann D., Cole S., Danos O., Retzel E., Tiollais P., Haase A., Wain-Hobson S.: Nucleotide sequence of the Visna lentivirus: relationship to the AIDS virus.Cell 42, 369–382 (1985).
Author information
Authors and Affiliations
Additional information
This work was supported by theGrant Agency of the Czech Republic, grant no. 524/01/0819, and by theWellcome Trust.
Rights and permissions
About this article
Cite this article
Celer, V., Blažek, D., Navrátilová, I. et al. Recombinant single-chain Fv antibodies that recognize the p25 protein of the Maedi-Visna virus. Folia Microbiol 48, 435–440 (2003). https://doi.org/10.1007/BF02931380
Received:
Issue Date:
DOI: https://doi.org/10.1007/BF02931380